Tilray | TRLY - Ebitda

Hisse Senedi Fiyatı
7.18
Günlük Değişim
-0.10 -1.37%
Aylık
-26.36%
Yıllık
1,039.68%
Q2 Tahmin
7.13




Ebitda Değişiklik Tarih
Acasti Pharma USD -2.45M 735K 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Cronos Group USD -1.41M 1.86M 2026-03
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Moderna USD -790M 582M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Organon & Co USD 415M 32M 2026-03
Revvity USD 272.91M 24M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1.05B 46.4M 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zealand Pharma A/S -727.47M 285.54M 2025-12